Skip to content

A study on the brain network mechanism of post-stroke depression based on near-infrared functional brain imaging technology

A study on the brain network mechanism of post-stroke depression based on near-infrared functional brain imaging technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093089
Enrollment
Unknown
Registered
2024-11-28
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke depression(PSD)

Interventions

Non-depression after stroke:None
Mild depression after stroke:None
Moderate depression after stroke:None

Sponsors

Wenzhou Hospital of Traditional Chinese Medicine Affiliated of Zhejiang University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Meets defined diagnostic criteria for post-stroke depression, age between 18-70 years old, male and female; 2.stroke duration of 1-12 months; 3. Initial depression, HAMD-17 score = 8 points; 4.Patients with stable vital signs, clear consciousness, able to carry out basic communication and co-operate in completing the scale assessment; 5. Willing to cooperate with the whole trial process and sign the relevant informed consent form; 6.Right sharp hand.

Exclusion criteria

Exclusion criteria: 1. Those who do not meet the diagnostic criteria for post-stroke depression and are younger than 18 years old or older than 70 years old; 2. Those who have a history of mental illness caused by other reasons before the occurrence of stroke, or those who have suicidal tendency;3.Those who had depression for more than half a year; 4.Those who have a history of taking anti-anxiety and depression drugs within 2 weeks before enrolment; 5.Patients with severe systemic disorders, unstable vital signs, or severe heart, liver, kidney and other important organ failure;6. Those with impaired consciousness, severe aphasia, and severe cognitive impairment (MMSE = 9 points), which affects communication; 7.Those who are intolerant to antidepressant drugs (e.g., with prolonged QT interval, or congenital QT syndrome) or allergic; 8.Patients with unstable epilepsy control;9. Pregnant and lactating women; 10.Those who are not willing to co-operate to complete the follow-up of this study;

Design outcomes

Primary

MeasureTime frame
prefrontal cortex oximetry;Hamilton Depression Scale (17-item) scores;

Secondary

MeasureTime frame
Self-Depression Scale (SDS) scores;

Countries

China

Contacts

Public ContactZhi Yinghao

Wenzhou Hospital of Traditional Chinese Medicine Affiliated of Zhejiang University of Traditional Chinese Medicine

43914515@qq.com+86 137 5847 2924

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026